2-Hydroxyisobutyric acid → 3-(4-Bromo-3,5-dimethyl-phenyl)-5-(2-hydroxy-prop-2-yl)-[1,2,4]oxadiazole
반응식
F[B-](F)(F)F.N1(OC(N(C)C)=[N+](C)C)C2C=CC=CC=2N=N1.[OH:23][C:24]([CH3:29])([CH3:28])[C:25](O)=[O:26].C(N(CC)C(C)C)(C)C.[Br:39][C:40]1[C:49]([CH3:50])=[CH:48][C:43]([C:44]([NH:46]O)=[NH:45])=[CH:42][C:41]=1[CH3:51]>CN(C)C=O.O>[Br:39][C:40]1[C:49]([CH3:50])=[CH:48][C:43]([C:44]2[N:45]=[C:25]([C:24]([OH:23])([CH3:29])[CH3:28])[O:26][N:46]=2)=[CH:42][C:41]=1[CH3:51]참가 물질
반응물 4
생성물 1
시약·촉매·용매 2
실험 절차
2-(Benzotriazol-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate (TBTU; 0.55 g) is added to a solution of 2-hydroxy-isobutyric acid (0.18 g) and N,N-diisopropyl-ethylamine (1.4 mL) in N,N-dimethylformamide (5 mL) at room temperature. The solution is stirred at room temperature for 10 min prior to the addition of 4-bromo-N-hydroxy-3,5-dimethyl-benzamidine (0.40 g). The solution is stirred at room temperature for another 10 min and then at 110° C. overnight. After cooling to room temperature, water is added and the resulting mixture is extracted with ethyl acetate. The combined extract is washed with brine, dried (MgSO4), and concentrated. The residue is chromatographed on reversed phase (HPLC; acetonitrile/water/trifluoroacetic acid) to give the title compound. LC (method 11): tR=1.16 min; Mass spectrum (ESI+): m/z=313/315 (Br) [M+H]+.
후처리
- stirringThe solution is stirred at room temperature for another 10 min
- customat 110° C.
- customovernight
- temperatureAfter cooling to room temperature
- extractionthe resulting mixture is extracted with ethyl acetate
- extractionThe combined extract
- washis washed with brine
- dry with materialdried (MgSO4)
- concentrationconcentrated
- customThe residue is chromatographed on reversed phase (HPLC; acetonitrile/water/trifluoroacetic acid)
출처 및 근거
- ORD 기록
- ord-5bcb0c5e4821451c87051ea4f60e2340
- 출처 데이터셋
- uspto-grants-2014_02
- 특허 번호
- US08642585B2
반응 노트
불러오는 중…